Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease-Reference-Cited by-同舟云学术

Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease

Published:2016-03-23 Issue:8 Volume:36 Page:1221-1229
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Braza-Boïls Aitana¹,Marí-Alexandre Josep¹,Molina Pilar²,Arnau Miguel A.³,Barceló-Molina Moisés¹,Domingo Diana³,Girbes Javier⁴,Giner Juan²,Martínez-Dolz Luis³,Zorio Esther³

Affiliation:

1. Instituto de Investigación Sanitaria La Fe; Valencia Spain

2. Servicio de Patología; Instituto de Medicina Legal; Valencia Spain

3. Servcicio de Cardiología; Hospital Universitario y Politécnico La Fe; Valencia Spain

4. Servicio de Análisis Clínicos; Hospital Universitario Dr. Peset; Valencia Spain

Funder

Instituto de Salud Carlos III

FEDER “Union Europea, Una forma de hacer Europa”

Premio López Borrasca-SETH

Sara Borrell Grant

Predoctoral Grant

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13097/fullpdf

Reference45 articles.

1. Task force on sudden cardiac death of the European society of cardiology;Priori;Eur Heart J,2001

2. Population-based study of out-of-hospital sudden cardiovascular death: incidence and causes of death in middle-aged adults;Morentin;Rev Esp Cardiol,2011

3. Nonalcoholic fatty liver disease;Adams;Ann Epidemiol,2007

4. Non-alcoholic fatty liver disease: the mist gradually clears;deAlwis;J Hepatol,2008

5. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity;Browning;Hepatology,2004

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 6-methylcoumarin/miR-122 suppresses hepatic Sortilin-mediated ApoB-100 secretion to attenuate aortic atherosclerosis;Cellular Signalling;2024-12

2. Cardiac abnormalities pre- and post-liver transplantation for metabolic dysfunction-associated steatohepatitis – Evidence and special considerations;Journal of Liver Transplantation;2024-08

3. Revolutionizing HCV Therapy: microRNA Approaches in New Era of Treatment;Liver Cancer - Multidisciplinary Approach;2024-07-11

4. A Systematic Review of Statins for the Treatment of Nonalcoholic Steatohepatitis: Safety, Efficacy, and Mechanism of Action;Molecules;2024-04-19

5. Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease;Journal of Genetic Engineering and Biotechnology;2023-12